FDA approves Hovilpri for treating herpes lesions

Regulatory Approvals — FDA approves Hovilpri for treating herpes lesions  Outbreak News Today

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. October 12, 2026.

By